These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 37259830)
41. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: a single center experience. Goker H; Ozdemir E; Uz B; Buyukasik Y; Turgut M; Serefhanoglu S; Aksu S; Sayinalp N; Haznedaroglu IC; Tekin F; Karacan Y; Unal S; Eliacik E; Isik A; Ozcebe OI Transfus Apher Sci; 2013 Dec; 49(3):590-9. PubMed ID: 23981652 [TBL] [Abstract][Full Text] [Related]
42. Relative Telomere Length before Hematopoietic Cell Transplantation and Outcome after Unrelated Donor Hematopoietic Cell Transplantation for Acute Leukemia. Wang Y; Wang T; Dagnall C; Haagenson M; Spellman SR; Hicks B; Jones K; Lee SJ; Savage SA; Gadalla SM Biol Blood Marrow Transplant; 2017 Jul; 23(7):1054-1058. PubMed ID: 28389255 [TBL] [Abstract][Full Text] [Related]
44. Decreased Mortality in 1-Year Survivors of Umbilical Cord Blood Transplant vs. Matched Related or Matched Unrelated Donor Transplant in Patients with Hematologic Malignancies. Bohannon L; Tang H; Page K; Ren Y; Jung SH; Artica A; Britt A; Islam P; Siamakpour-Reihani S; Giri V; Lew M; Kelly M; Choi T; Gasparetto C; Long G; Lopez R; Rizzieri D; Sarantopoulos S; Chao N; Horwitz M; Sung A Transplant Cell Ther; 2021 Aug; 27(8):669.e1-669.e8. PubMed ID: 33991725 [TBL] [Abstract][Full Text] [Related]
45. Comparable survival outcome between transplantation from haploidentical donor and matched related donor or unrelated donor for severe aplastic anemia patients aged 40 years and older: A retrospective multicenter cohort study. Zhang YY; Mo WJ; Zuo YY; Zhou M; Zhang XH; Wang Y; Li YM; Zhang YP; Chen YH; Chen XW; Mo XD; Wang CX; Lin F; Huang XJ; Wang SQ; Xu LP Clin Transplant; 2020 Mar; 34(3):e13810. PubMed ID: 32011059 [TBL] [Abstract][Full Text] [Related]
46. Comparison of Hematopoietic Stem Cell Transplantation Outcomes Using Matched Sibling Donors, Haploidentical Donors, and Immunosuppressive Therapy for Patients With Acquired Aplastic Anemia. Zhang Y; Huo J; Liu L; Shen Y; Chen J; Zhang T; Chen X; Pang A; Yang D; Zhang R; Ma Q; Zhai W; He Y; Wei J; Jiang E; Han M; Zheng Y; Feng S Front Immunol; 2022; 13():837335. PubMed ID: 35178053 [TBL] [Abstract][Full Text] [Related]
47. Effect of increased dose of total body irradiation on graft failure associated with HLA-haploidentical transplantation in patients with severe haemoglobinopathies: a prospective clinical trial. Bolaños-Meade J; Cooke KR; Gamper CJ; Ali SA; Ambinder RF; Borrello IM; Fuchs EJ; Gladstone DE; Gocke CB; Huff CA; Luznik L; Swinnen LJ; Symons HJ; Terezakis SA; Wagner-Johnston N; Jones RJ; Brodsky RA Lancet Haematol; 2019 Apr; 6(4):e183-e193. PubMed ID: 30878319 [TBL] [Abstract][Full Text] [Related]
48. Reduced Intensity Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Pediatric Inherited Immune Deficiencies and Bone Marrow Failure Syndromes. Klein OR; Bapty S; Lederman HM; Younger MEM; Zambidis ET; Jones RJ; Cooke KR; Symons HJ J Clin Immunol; 2021 Feb; 41(2):414-426. PubMed ID: 33159275 [TBL] [Abstract][Full Text] [Related]
49. Clinical effect of reduced-intensity conditioning regimen containing antithymocyte globulin for hematopoietic cell transplantation from unrelated-donors. Lee KH; Choi SJ; Lee JH; Lee JH; Kim DY; Seol M; Lee YS; Kang YA; Jeon M; Yun SC; Joo YD; Lee WS; Kang MJ; Kim H; Park JH; Bae SH; Ryoo HM; Kim MK; Hyun MS Am J Hematol; 2011 May; 86(5):399-405. PubMed ID: 21523798 [TBL] [Abstract][Full Text] [Related]
50. The effect of intensity of conditioning regimen on the outcome of HSCT in children with sickle cell disease. Alsultan A; Abujoub R; Elbashir E; Essa MF Clin Transplant; 2022 Nov; 36(11):e14787. PubMed ID: 35929611 [TBL] [Abstract][Full Text] [Related]
51. Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission. Rashidi A; Hamadani M; Zhang MJ; Wang HL; Abdel-Azim H; Aljurf M; Assal A; Bajel A; Bashey A; Battiwalla M; Beitinjaneh AM; Bejanyan N; Bhatt VR; Bolaños-Meade J; Byrne M; Cahn JY; Cairo M; Ciurea S; Copelan E; Cutler C; Daly A; Diaz MA; Farhadfar N; Gale RP; Ganguly S; Grunwald MR; Hahn T; Hashmi S; Hildebrandt GC; Holland HK; Hossain N; Kanakry CG; Kharfan-Dabaja MA; Khera N; Koc Y; Lazarus HM; Lee JW; Maertens J; Martino R; McGuirk J; Munker R; Murthy HS; Nakamura R; Nathan S; Nishihori T; Palmisiano N; Patel S; Pidala J; Olin R; Olsson RF; Oran B; Ringden O; Rizzieri D; Rowe J; Savoie ML; Schultz KR; Seo S; Shaffer BC; Singh A; Solh M; Stockerl-Goldstein K; Verdonck LF; Wagner J; Waller EK; De Lima M; Sandmaier BM; Litzow M; Weisdorf D; Romee R; Saber W Blood Adv; 2019 Jun; 3(12):1826-1836. PubMed ID: 31201170 [TBL] [Abstract][Full Text] [Related]
53. Outcome of aplastic anemia in adolescence: a survey of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation. Dufour C; Pillon M; Passweg J; Socié G; Bacigalupo A; Franceschetto G; Carraro E; Oneto R; Risitano AM; Peffault de Latour R; Tichelli A; Rovo A; Peters C; Hoechsmann B; Samarasinghe S; Kulasekararaj AG; Schrezenmeier H; Aljurf M; Marsh J Haematologica; 2014 Oct; 99(10):1574-81. PubMed ID: 25085353 [TBL] [Abstract][Full Text] [Related]
54. Hematopoietic stem cell transplantation with umbilical cord multipotent stromal cell infusion for the treatment of aplastic anemia--a single-center experience. Wang H; Wang Z; Zheng X; Ding L; Zhu L; Yan H; Guo Z Cytotherapy; 2013 Sep; 15(9):1118-25. PubMed ID: 23806238 [TBL] [Abstract][Full Text] [Related]
55. Busulfan, fludarabine, and melphalan are effective conditioning for pediatric and young adult patients with myeloid malignancies underdoing matched sibling or alternative donor transplantation. Truscott L; Pariury H; Hanmod S; Davini M; de la Maza M; Sapp LN; Staples K; Proytcheva M; Katsanis E Pediatr Blood Cancer; 2023 Feb; 70(2):e30102. PubMed ID: 36394072 [TBL] [Abstract][Full Text] [Related]
56. Outcomes after Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide: A Systematic Review and Meta-Analysis Comparing Myeloablative with Reduced-Intensity Conditioning Regimens and Bone Marrow with Peripheral Blood Stem Cell Grafts. Arcuri LJ; Hamerschlak N; Rocha V; Bonfim C; Kerbauy MN Transplant Cell Ther; 2021 Sep; 27(9):782.e1-782.e7. PubMed ID: 34146733 [TBL] [Abstract][Full Text] [Related]
57. Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Jagasia M; Arora M; Flowers ME; Chao NJ; McCarthy PL; Cutler CS; Urbano-Ispizua A; Pavletic SZ; Haagenson MD; Zhang MJ; Antin JH; Bolwell BJ; Bredeson C; Cahn JY; Cairo M; Gale RP; Gupta V; Lee SJ; Litzow M; Weisdorf DJ; Horowitz MM; Hahn T Blood; 2012 Jan; 119(1):296-307. PubMed ID: 22010102 [TBL] [Abstract][Full Text] [Related]
58. Outcomes of Allogeneic Stem Cell Transplant for Elderly Patients with Hematologic Malignancies. Hsu J; Chen Z; Shore T; Gergis U; Mayer S; Phillips A; Guarner D; Hsu YM; Cushing MM; Van Besien K Biol Blood Marrow Transplant; 2020 Apr; 26(4):789-797. PubMed ID: 31891814 [TBL] [Abstract][Full Text] [Related]
59. Haploidentical Hematopoietic Cell Transplantation Using Post-transplant Cyclophosphamide for Children with Non-malignant Diseases. Hashem H; Najjar R; Abu-Shanap M; Khattab E; Rihani R; Tbakhi A; Sultan I J Clin Immunol; 2021 Nov; 41(8):1754-1761. PubMed ID: 34355352 [TBL] [Abstract][Full Text] [Related]